Bioxetin

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Bioxetin

Quick Facts: Bioxetin (Fluoxetine)

Property Description
Active ingredient Fluoxetine hydrochloride
Primary Class Selective Serotonin Reuptake Inhibitor (SSRI)
General Purpose Modulating mood and emotional balance
Available Forms Capsules, tablets, oral solution
Regulatory Status Prescription-only medicine (Rx)

What is Bioxetin?

Bioxetin is a specific medicinal preparation containing Fluoxetine hydrochloride, which functions as a psychotropic agent and is officially categorized as an antidepressant. This classification places the drug within the Selective Serotonin Reuptake Inhibitor (SSRI) class, signifying its highly targeted action on chemical signaling in the brain. The medication is a prescription-only product, synthesized for clinical use as an effective compound for central nervous system modulation.

Identity, Composition, and Unique Features

The therapeutic core of Bioxetin is the International Nonproprietary Name (INN) compound, Fluoxetine, a synthetic chemical compound formulated for oral administration. Bioxetin is a single-active-ingredient product, commonly supplied as capsules, tablets, and oral solution, ensuring versatile delivery of the standardized component. A unique characteristic of Fluoxetine is its comparatively long half-life, which distinguishes it from many other SSRIs and is a factor in its persistent therapeutic activity.

Pharmacological Class and General Purpose

The general purpose of Bioxetin is to support the brain’s ability to maintain stable emotional regulation. As an SSRI, its function is based on selective inhibition of presynaptic serotonin reuptake, which increases the functional availability of serotonin in key neural pathways. This mechanism is the foundational action by which Bioxetin helps to restore mental equilibrium and reduce the severity of persistent psychological symptoms.

Regulatory References

  1. Fluoxetine: MedlinePlus Drug Information
  2. Fluoxetine - StatPearls - NCBI Bookshelf - NIH

What side effects are possible with Bioxetin?

Possible Side Effects and Safety Information

The safety profile of Bioxetin (Fluoxetine) is formally documented in regulatory labeling, with adverse reactions classified by frequency and affected body systems. These classifications demonstrate that the documented risks are diverse, affecting multiple body systems, and are not uniform across all patients or all time periods of use.

Frequency-Classified Adverse Reactions

The most frequently reported events, based on clinical trial data and regulatory classification, include:

Classification Common Side Effects Affected System(s)
Very Common (> 1 in 10) Headache, Insomnia, Nausea, Diarrhea, Asthenia Nervous System, Gastrointestinal
Common (up to 1 in 10) Anxiety, Tremor, Dry Mouth, Anorexia, Decreased Libido Psychiatric, Nervous System, Gastrointestinal, Reproductive

Serious Adverse Reactions and Constraints

Official labeling identifies serious reactions and important safety constraints. An increased risk of Suicidal Thoughts and Behaviors is noted in children, adolescents, and young adults (up to age 24), particularly during treatment initiation or dose changes. The medication carries a risk for conditions such as Serotonin Syndrome, often associated with co-administration of other serotonergic agents, and the potential for QT Prolongation and serious cardiac arrhythmias.

Safety constraints dictate that Bioxetin must not be used concurrently with non-selective Monoamine Oxidase Inhibitors (MAOIs) or certain drugs like Thioridazine and Pimozide due to the risk of severe interaction.

Population-Specific Safety Notes

The labeling notes specific considerations for certain patient groups, including the heightened risk of Hyponatremia (low sodium levels) in older adults and potential long-term safety concerns regarding growth and sexual maturation in the pediatric population. The risk of suicidality is emphasized during the initial treatment weeks and following dose adjustments.

Overdose and Emergency Response

Overdose and when to seek help

This information is based strictly on authoritative governmental regulatory documents regarding the management of Bioxetin (fluoxetine) overdose.


Documented Overdose Manifestations

System Affected Common Findings (as stated in regulatory labels)
Central Nervous System (CNS) Seizures, tremor, agitation, CNS excitability, or altered mental status (ranging to coma).
Cardiovascular Tachycardia (rapid heartbeat), or EKG abnormalities such as QRS widening or ventricular arrhythmia.
Gastrointestinal (GI) Nausea and vomiting.

Serious consequences, including death, have been reported in overdoses, particularly when Bioxetin is ingested in large quantities or in combination with other substances or alcohol. The long half-life of Bioxetin and its active metabolite may necessitate prolonged observation following a suspected overdose.


When Immediate Medical Help is Required

Immediate medical attention must be sought for any suspected overdose.

Emergency Actions:

  • Contact a certified Poison Control Center or emergency medical services immediately.
  • Management should involve general supportive measures to address symptoms.
  • Due to potential cardiac risk, continuous monitoring of vital signs, including an ECG (electrocardiogram), is required for observation of the patient.

The official regulatory profile emphasizes that although many overdoses are considered minimally toxic, the risk for serious and life-threatening events is present and increases significantly with co-ingestion, requiring prompt professional intervention.

Therapeutic Uses of Bioxetin

Bioxetin is applied across distinct clinical domains to provide supportive relief and maintain functional stability in conditions where symptoms create noticeable interference with daily functioning. It is relevant in contexts where additional symptomatic support is needed.

The medication is commonly used to help manage symptoms related to Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), Panic Disorder, Bulimia Nervosa, and Premenstrual Dysphoric Disorder (PMDD). This supportive use helps address symptom clusters that may become intense or disruptive, such as persistent sadness, intrusive thoughts, and heightened emotional tension.

“It is commonly used across conditions presenting with acute episodes and relevant in conditions characterized by periods of heightened symptoms.”

This medication offers symptomatic relief that helps patients cope more steadily with difficult episodes, contributing to easing the overall symptom load and assisting with maintaining functional stability when symptoms interfere with routine activities. It supports general well-being during symptomatic phases.

Quick Fact: Relief for Mood and Anxiety
Primary Focus Affective disorders, pathological anxiety, and specific behavioral cycles.
Key Benefit Contributes to improved comfort during periods of heightened symptoms.
Use Scenario Applied in contexts where supportive symptom management is appropriate.

Regulatory References

  1. NIH StatPearls overview

Eligibility and Restrictions for Use

Bioxetin, which contains the active substance fluoxetine, is subject to specific regulatory rules defining who can and cannot use the medicine.

Populations that Must Not Use Fluoxetine (Contraindications)

Official documents strictly prohibit use in the following situations:

  • Known Hypersensitivity to fluoxetine or any of its components.
  • Concomitant Use of Monoamine Oxidase Inhibitors (MAOIs): Fluoxetine must not be used concurrently with an MAOI intended to treat psychiatric disorders, nor within 14 days of discontinuing an MAOI. A washout period of at least five weeks is required after stopping fluoxetine before starting an MAOI.
  • Concomitant Use of Pimozide or Thioridazine: Use with pimozide is prohibited due to the risk of QT prolongation. Use with thioridazine is also contraindicated, and a five-week washout period is required after discontinuing fluoxetine before thioridazine can be started.

Eligibility Constraints and Special Populations

  • Age: Safety and effectiveness are not established for pediatric patients below certain ages for specific uses (e.g., typically under 8 years for Major Depressive Disorder or under 7 years for Obsessive Compulsive Disorder).
  • Hepatic Impairment: Due to the drug's metabolism in the liver, patients with hepatic impairment (e.g., cirrhosis) may require a lower or less frequent dosage.
  • Pregnancy and Lactation: Use during pregnancy is permitted only if the potential benefit justifies the potential risks to the fetus. Breastfeeding is not recommended while taking fluoxetine.

What should I know about interactions with other medicines?

Bioxetin Interactions with other medicines and products

Bioxetin’s official interaction profile is defined by two primary regulatory concerns: pharmacokinetic inhibition and pharmacodynamic reinforcement.

Contraindicated Combinations and Timing Rules

The co-administration of Bioxetin (fluoxetine) is strictly contraindicated with Monoamine Oxidase Inhibitors (MAOIs), Pimozide, and Thioridazine. This restriction extends to linezolid and intravenous methylene blue due to their MAOI activity. Owing to Bioxetin’s long half-life, a mandatory washout period of at least five weeks must pass after discontinuing Bioxetin before initiating an MAOI, as specified in regulatory labeling.


Metabolic and Pharmacodynamic Risks

Bioxetin is officially categorized as a potent inhibitor of the CYP2D6 enzyme pathway. This pharmacokinetic effect leads to reduced clearance and may increase the plasma concentration of co-administered medicines metabolized by CYP2D6, including certain antipsychotics and tricyclic antidepressants. A distinct pharmacodynamic risk involves combining Bioxetin with other serotonergic agents, such as triptans or tramadol, which can potentiate the risk of Serotonin Syndrome. Furthermore, co-administration with drugs that interfere with hemostasis, such as NSAIDs or Warfarin, may potentiate the risk of abnormal bleeding. In the presence of hepatic impairment, the drug’s elimination is slowed, which heightens the risk of all exposure-related interactions.

Mechanism of Action

Bioxetin (fluoxetine) operates within the central nervous system to alter neuronal signaling patterns by influencing a specific neurotransmitter system.


Selective Neurotransmitter Modulation

The core molecular action is the selective inhibition of the serotonin transporter (SERT), a protein located on the presynaptic neuronal membrane. By blocking the reuptake of the neurotransmitter serotonin (5-HT), Bioxetin increases the concentration and prolongs the action of 5-HT within the synaptic cleft. This targeted action is a modified early molecular step in the serotonergic pathway, which alters subsequent signaling within targeted neural pathways and results in an adjustment of physiological response patterns.


Regulation of Downstream Receptor Activity

The sustained increase in synaptic serotonin leads to altered binding patterns and adaptive changes in postsynaptic serotonin receptors (e.g., 5-HT2C receptors). These modifications in receptor activity initiate downstream signaling sequences that influence feedback regulation within neural circuits. This molecular cascade alters the effects of elevated mediator activity and yields measurable changes in overall physiological output, which defines the drug's resultant effect profile.

Dosage and Administration Information

Bioxetin is administered exclusively by the oral route, available in capsule, tablet, and oral solution forms. Dosing recommendations vary based on the condition being addressed, but generally follow a once-daily schedule, typically taken in the morning, which may be done with or without food.

Dosing Regimens

Indication Starting Dose (Adult) Maintenance Range (Adult) Maximum Dose
Major Depressive Disorder (MDD) 20 mg/day 20 mg to 60 mg/day 80 mg/day
Obsessive-Compulsive Disorder (OCD) 20 mg/day 20 mg to 60 mg/day 80 mg/day
Bulimia Nervosa 60 mg/day 60 mg/day 60 mg/day

Frequency and Time-Based Use

The standard adult starting dose for MDD and OCD is 20 mg taken once daily. For certain indications, the dose may be administered once daily or in divided doses (morning and noon) if the total daily dose is above 20 mg. A specialized 90 mg delayed-release capsule is also a once-weekly option for MDD maintenance. Due to the compound’s long half-life, dose adjustments are typically considered only after several weeks of therapy. Discontinuation of the medicine requires a gradual reduction in dose over one to two weeks.

Population-Specific Use and Handling

Specific instructions exist for certain populations. For older adults, caution is advised when increasing the dose, and the total daily amount should generally not exceed 40 mg. In patients with hepatic impairment, a lower or less frequent dosage, such as 20 mg every second day, is recommended. For pediatric patients (children and adolescents) treating MDD, the initial dose is often 10 mg/day, increasing to 20 mg/day after one week. If the oral solution is used, it must be measured with a calibrated device to ensure proper administration.

Recent Clinical Evidence

Bioxetin: Recent Clinical Evidence

Research has explored the clinical profile of this compound, primarily focusing on its use in certain chronic pain and mood-related conditions. Studies often compare outcomes against a placebo or standard-of-care treatments to evaluate its potential therapeutic role.

Efficacy in Symptom Management

Trials investigated whether Bioxetin was associated with changes in patient-reported pain intensity and overall function. For instance, in an 8-week, placebo-controlled study involving patients with persistent somatoform pain disorder, researchers documented a significant difference in pain measures compared to placebo after two weeks. This observed effect was noted to be related to the duration of treatment, with patients also experiencing depressive symptoms often showing a more pronounced analgesic effect in this specific trial.

Evidence for the compound's use in various chronic pain conditions (excluding headache) is often categorized as low-certainty in broad systematic reviews encompassing multiple antidepressant classes. Researchers continue to examine its effect on pain reduction, physical function, and quality of life in these populations.

Safety and Tolerability Profile

Studies reported on the safety profile of Bioxetin, documenting adverse event frequency across different patient groups. In the context of the pain disorder trial, researchers noted that adverse effects were scarcely found.

Common adverse events (AEs) reported across the clinical program typically include mild symptoms such as headache, fatigue, and gastrointestinal upset. The overall incidence of serious adverse events (SAEs) has been documented in the research to date. No specific, consistent organ-system toxicity was identified across the trial data.

Key Studies & References

  1. Efficacy of Antidepressants in Chronic Non-Cancer Pain: A Systematic Review and Meta-analysis
  2. A randomized, placebo-controlled trial of Bioxetin in patients with persistent somatoform pain disorder
  3. Antidepressant Treatment for Chronic Pain Management: Clinical Practice Guideline

Frequently Asked Questions (FAQ)

Common questions about Bioxetin (FAQ)


Q: Is there a list of common side effects that are usually mild?

A: Official regulatory documents classify adverse reactions based on how often they occur. Adverse reactions that are reported most frequently include events such as headache, nausea, diarrhea, and insomnia, which occur more frequently than other reported events. This information is found in the official product labeling.


Q: What are the signs of a serious reaction to Bioxetin that I should watch for?

A: Patient information from regulatory agencies advises watching for new or sudden, severe changes in mood, behavior, or feelings. This includes intense agitation, panic attacks, new thoughts of self-harm, or other unusual changes in behavior. Individuals who note these changes should contact a healthcare professional immediately.


Q: Can Bioxetin change the quality of my sleep?

A: Official documents report that Bioxetin may affect sleep. Insomnia (trouble sleeping) and unusual dreams are listed among the commonly reported side effects associated with the medicine. Changes that are persistent or concerning are often discussed with a healthcare professional.


Q: Is it common to feel a bit more anxious when first starting Bioxetin?

A: Official labeling lists both anxiety and nervousness as commonly reported side effects. Regulatory agencies recommend close monitoring for new or worsening anxiety or panic attacks, particularly when treatment is started or the dosage is changed.


Q: Does Bioxetin have known interactions with alcohol?

A: Co-administering Bioxetin with alcohol may increase central nervous system side effects. These can include effects such as dizziness, drowsiness, and difficulty concentrating, according to regulatory drug safety information.


Q: Does Bioxetin interact with herbal remedies like St. John's wort?

A: Official interaction warnings specifically address the use of Bioxetin with St. John’s wort. Combining these may significantly increase the risk of Serotonin Syndrome, a potentially serious condition.


Q: Can I use Bioxetin if I am taking blood thinners?

A: Regulatory warnings state that co-administration with drugs that interfere with blood clotting, such as warfarin or other blood thinners (antiplatelet agents), may increase the possibility of abnormal bleeding. This is an official safety consideration.


Q: Is Bioxetin transferred through breast milk?

A: Regulatory documents confirm that fluoxetine and its active metabolite are reported to pass into breast milk. Official labeling advises that the decision to nurse be made only after carefully considering the potential risks to the infant.


Q: What is the typical time frame to evaluate if Bioxetin is working?

A: It may take four to five weeks or longer before the full, stable benefit of the medication is felt. Dose adjustments, if needed, are generally considered only after several weeks of continuous therapy.


Q: How quickly does Bioxetin typically start to show effects?

A: Due to the drug's pharmacological profile, which includes a relatively slow elimination rate, it typically takes four to five weeks of consistent use for the medicine and its active component to reach stable concentrations in the body. This establishment of stable levels is considered necessary for the full effect.


Q: Do you always have to keep taking Bioxetin once you start?

A: For long-term use, especially for maintenance periods longer than several months, regulatory documents recommend that the need for continued treatment should be periodically re-evaluated by a healthcare professional. Any decision to stop the medicine requires a gradual dose reduction.


Q: Can Bioxetin affect my ability to drive or operate machinery?

A: Official warnings indicate that Bioxetin has the potential to impair judgment, thinking, and motor skills. Regulatory labeling notes that individuals should use caution regarding activities such as driving a vehicle or operating hazardous machinery.


Q: Does Bioxetin cause weight gain or weight loss?

A: Official labeling notes that significant weight loss has occurred in some patients. Anorexia (loss of appetite) is also listed among the commonly reported adverse reactions associated with the medicine.


Q: Are there any over-the-counter supplements that shouldn't be taken with Bioxetin?

A: Official interaction warnings specifically address the use of Bioxetin with certain herbal supplements, such as St. John's wort, due to the potential for Serotonin Syndrome. The use of all supplements and over-the-counter products is best discussed with a healthcare provider.


Q: How long does Bioxetin stay in your system after the last use?

A: The active substance in Bioxetin has a long elimination half-life of 4 to 6 days after chronic use. Furthermore, its primary active metabolite has an even longer half-life, approximately 9 days, meaning the effects on the body can persist for several weeks after the last dose.


Q: Does Bioxetin lose its effectiveness over time?

A: Regulatory documents indicate that the drug's long-term effectiveness, specifically for use extending beyond 6 months, has not been systematically evaluated in certain placebo-controlled clinical trials. Therefore, the effect over very long periods of use is subject to individual patient monitoring.


Q: Can Bioxetin be used during pregnancy?

A: The official constraint states that use during pregnancy is permitted only if the potential benefit to the mother is determined to justify the potential risks to the fetus. This decision is made on a case-by-case basis by a healthcare provider.


Q: Does Bioxetin have any known effect on sexual function?

A: Official safety labeling indicates that the medicine may cause symptoms of sexual dysfunction. Specific adverse reactions listed in regulatory documents include decreased libido and impotence.


Q: Is it okay to use Bioxetin if I have a history of seizures?

A: Official warnings advise caution when using Bioxetin in patients who have a history of seizures or other conditions that could lower the seizure threshold. This information is included in the regulatory safety section.


Q: Can Bioxetin cause changes in mood or personality?

A: Regulatory patient information advises monitoring for new or sudden, severe changes in mood, behavior, and feelings, which may include unusual changes in behavior or aggression. These are considered important safety observations.


Q: Is it necessary to have blood tests while taking Bioxetin?

A: Official labeling notes the risk of a condition called hyponatremia (low sodium levels), particularly in older adults or those taking diuretics. This suggests that laboratory monitoring of blood sodium levels may be appropriate for certain patients.


Q: Does Bioxetin interact with cold or flu medicines?

A: Bioxetin can interact with specific components found in some cold and flu medicines. For example, ingredients like dextromethorphan may increase the risk of Serotonin Syndrome when combined with Bioxetin, according to drug interaction summaries.


Q: Is Bioxetin known to interact with caffeine?

A: Formal drug interaction studies conducted for Bioxetin have indicated no known clinically significant interaction with caffeine. This finding is included in the regulatory drug interaction research documentation.


Q: Why is Bioxetin sometimes prescribed at a lower starting amount?

A: Official dosage guidelines list lower starting doses for specific populations where the drug's metabolism or sensitivity may be altered. This includes recommendations for pediatric patients, older adults, and individuals with known hepatic (liver) impairment.


Q: Will Bioxetin 'cure' my condition?

A: The general purpose of the medicine is officially described as supporting the brain’s ability to maintain stable emotional regulation and reducing the severity of persistent symptoms. This mechanism is typical for the long-term management of chronic conditions, rather than a single cure.

How should Bioxetin be stored and disposed of?

How to Store and Dispose of Bioxetin (Fluoxetine)

This information is based on official government regulatory documents regarding the storage and disposal requirements for Fluoxetine products.

Official Storage Requirements

Requirement Specifics
Temperature Store at controlled room temperature, typically 20 to 25 C (68 to 77 F).
Protection Keep away from moisture, light, and excess heat. Do not freeze.
Container Keep medication in its original, tightly closed container. Do not store in high-moisture areas like the bathroom.
Child Safety Must be kept out of the sight and reach of children.

Official Disposal Protocol

Proper disposal is required to prevent environmental harm. Due to the active ingredient's classification as an environmental hazard, Bioxetin must not be flushed down the toilet or placed in household trash. Consult a pharmacist or local waste management service for instructions on returning or disposing of unused or expired medicine according to applicable local laws and regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Bioxetin found in:

A-Z Index: